Sexual risk behaviors among men who have sex with men using erectile dysfunction medications

AIDS Patient Care and STDs

Volumn 23, Issue 12, 2009, Pages 1017-1023

  Nettles, Christopher D ^a   Benotsch, Eric G ^b   Uban, Kristina A ^c  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL; TADALAFIL; VARDENAFIL;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE TRANSMISSION; EDUCATION; ERECTILE DYSFUNCTION; ETHNIC DIFFERENCE; HEALTH SURVEY; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; RISK ASSESSMENT; RISK REDUCTION; SEXUAL BEHAVIOR; SUBSTANCE ABUSE; UNSAFE SEX;

ADULT; ERECTILE DYSFUNCTION; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; MIDDLE AGED; PHOSPHODIESTERASE INHIBITORS; QUESTIONNAIRES; RISK-TAKING; UNSAFE SEX; YOUNG ADULT;

EID: 77149142233     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2009.0029     Document Type: Article

References (53)

1. Centers for Disease Control and Prevention. CDC HIV=AIDS Fact Sheet: HIV=AIDS among Men Who Have Sex With Men. Atlanta: US Department of Health and Human Services, July, 2005.
2. Centers for Disease Control and Prevention. Increases in HIV diagnoses-29 states, 1999-2000. MMWR Morb Mortal Wkly Rep 2003;52:1145-1148.
3. Centers for Disease Control and Prevention. Outbreak of syphilis among men who have sex with men-Southern California, 2000. MMWR Morb Mortal Wkly Rep 2001;50: 117-120.
4. Centers for Disease Control and Prevention. Primary and secondary syphilis among men who have sex with men- New York City, 2001. MMWR Morb Mortal Wkly Rep 2002;51:853-856.
5. Centers for Disease Control and Prevention. Primary and secondary syphilis-United States, 2000-2001.MMWR Morb Mortal Wkly Rep 2002;51:971-973.
6. Rietmeijer CA, Patnaik JL, Judson FN, Douglas JM. Increases in gonorrhea and sexual risk behaviors among men who have sex with men: A 12-year trend analysis at the Denver Metro Health Clinic. Sex Transm Dis 200;30:562-567.
7. Erbelding EJ, Chung S, Kamb ML, Irsin KL, Rompalo AM. New Sexually transmitted diseases in HIV-infected patients: Markers for onging HIV transmission behavior. J Acquir Immune Defic Syndr 2003;33:247-1242
8. Scheer S, Chu PL, Klausner JD, Katz MH, Schwarcz SK. Effects of highly active antiretroviral therapy on diagnoses of sexually transmitted diseases in people with AIDS. Lancet 2001;357:432-435.
9. Van de Ven P, Prestage G, Crawford J, Grulich A, Kippax S. Sexual risk behaviour increases and is associated with HIV optimism among HIV-negative and HIV-positive gay men in Sydney over the 4 year period to February 2000. AIDS 2000;14:2951-2953.
10. Sowell RL, Lindsey C, Spicer T. Group sex in gay men: Its meaning and HIV prevention implications. J Assoc Nurses AIDS Care 1998;9:59-71.
11. Delate T, Simmons VA, Motheral BR. Patterns of use of sildenafil among commercially insured adults in the United States: 1998-2002. Int J Impotence Res 2004;16:313-318.
12. Aldridge J, Measham F. Sildenafil (Viagra) is used as a recreational drug in England. BMJ 1999;318:669.
13. Graham NA, Polles A, Gold MS. Performance enhancing, non-prescription use of erectile dysfunction medications. J Addict Dis 25:61-68.
14. Sherr L, Bolding G, Maguire M, Elford J. Viagra use and sexual risk behavior among gay men in London. AIDS 2000; 14:2051-2053.
15. Mansergh G, Colfax G, Marks G, Rader M, Guzman R, Buchbinder S. The circuit party men's health survey: Findings and implications for gay and bisexual men. Am J Public Health 2001;91:953-958.
16. Kim AA, Kent CK, Klausner JD. Increased risk of HIV and sexually transmitted disease transmission among gay or bisexual men who use Viagra, San Francisco 2000-2001. AIDS 2002:15:1425-1428.
17. Chu PL, McFarland W, Gibson S, et al. Viagra use in a community recruited sample of men who have sex with men, San Francisco. J Acquir Immune Defic Syndr 2003;33: 191-193.
18. Spindler HH, Scheer, S, Chen SY, et al. Viagra, methamphetamine, and HIV risk: Results from a probability sample of MSM, San Francisco. Sex Transm Dis 2007;34:586-691.
19. Pantalone DW, Bimbi DS, Parsons JT. Motivations for recreational use of erectile enhancing medications in urban gay and bisexual men. Sex Transm Infect 2008;84:458-462.
20. Crosby R, DiClemente RJ. Use of recreational Viagra among men having sex with men. Sex Transm Infect 2004;80:466-468.
21. Paul J, Pollack L, Osmond D, Cantania JA. Viagra (sildenafil) use in a population-based sample of U.S. men who have sex with men. Sex Transm Infect 2005;32:531-533.
22. Jackson G. PDE-5 inhibitors and HIV risk: Current concepts and controversies. Int J Clin Pract 2005;59:1247-1248.
23. Swearingen SG, Klausner JD. Sildenafil use, sexual risk behavior, and risk for sexually transmitted diseases, including HIV infection. Am J Med 2005;118:571-577.
24. Rosen RC, McKenna KE. PDE-5 inhibition and sexual response: Pharmacological mechanisms and clinical outcomes. Annu Rev Sex Res 2002;13:36-88.
25. Padma-Nathan H, Christ G, Adaikan, G, et al. Original research - Phosphodiesterase inhibitor therapy for ED: Pharmacotherapy for erectile dysfunction. J Sex Med 2004;1: 128-140.
26. Ende A, Lo Re V, DiNubile M, Mounzer K. Erectile dysfunction in an urban HIV-positive population. AIDS Patient Care STDs 2006;20:75-78.
27. Lallemand F, Salhi Y, Linard F, Giami A, Rozenbaum W. Sexual dysfunction in 156 ambulatory HIV-infected men receiving highly active antiretroviral therapy combinations with and without protease inhibitors. J Acquir Immune Defic Syndr 2002;30:187-190.
28. Cachay E, Mar-Tang M, Matthews C. Screening for potentially transmitting sexual risk behaviors, urethral sexually transmitted infection, and sildenafil use among males entering care for HIV infection. AIDS Patient Care STDs 2004; 18:349-354.
29. Trotta MP, Ammassari A, Murri R, et al. Self-reported sexual dysfunction is frequent among HIV-infected persons and is associated with suboptimal adherence to antiretrovirals. AIDS Patient Care STDs 2008;22:291-299.
30. Crum-Cianflone N, Barvo M, Hale B, et al. Erectile dysfunction and hypogonadism among men with HIV. AIDS Patient Care STDs 2007;21:9-19.
31. Kell P, Sadeghi-Nejad H, Price D. An ethical dilemma: Erectile dysfunction in the HIV-positive patient: To treat or not to treat. Int J STD AIDS 2002;13:355-357.
32. Rosen RC, Catania JA, Ehrhardt AA, et al. The Bolger conference on PDE-5 inhibition and HIV risk: Implications for health policy and prevention. J Sex Med 2006;3:960-975.
33. Gore-Felton C, Kalichman S, Brondino M, Benotsch EG, Cage M, DiFonzo K. Childhood sexual abuse and HIV risk among men who have sex with men: Initial test of a conceptual model. J Fam Violence 2006;21:263-270.
34. Grov C, Parsons JT, Bimbi DS. Sexual risk behavior and venues for meeting sex partners: An intercept survey of gay and bisexual men in LA and NYC. AIDS Behav 2007;11: 915-926.
35. Halkitis PN, Parsons JT. Recreational drug use and HIV-risk sexual behavior among men frequenting gay social venues. J Gay Lesb Soc Serv 2002;14:19-38.
36. The Center. Pridefest. 2008; http:==pridefestdenver.org=index .html (Last accessed December 26, 2008)
37. Kalichman SC, Gore-Felton C, Benotsch E, Cage M, Rompa D. Trauma symptoms, sexual behaviors, and substance abuse: Correlates of childhood sexual abuse and HIV risks among men who have sex with men. J Child Sex Abus 2004;13:1-15.
38. Colorado Department of Public Health and Environment. HIV and AIDS in Colorado: Surveillance Report (Revised December 2007). 2000; www.cdphe.state.co.us=dc=HIVand STD=HIV-STDSurv=MonitortheEpi.pdf. (Last accessed May 6, 2008).
39. Benotsch EG, Kalichman S, Cage M. Men who have met sex partners via the Internet: Prevalence, predictors, and implications for HIV prevention. Arch Sex Behav 2002;31:177-183.
40. Benotsch EG, Seeley S, Mikytuck J, Pinkerton SD, Nettles CD, Ragsdale K. Substance use, medications for sexual facilitation, and sexual risk behavior among traveling men who have sex with men. Sex Transm Dis 2006;33:706-711.
41. Benotsch EG, Mikytuck J, Ragsdale K, Pinkerton SD. Sexual risk and HIV acquisition among MSM travelers to Key West, Florida: A mathematical modeling analysis. AIDS Patient Care STDs 2006;20:549-556.
42. Kauth MR, St. Lawrence JS, Kelly JA. Reliability of retrospective assessments of sexual hiv risk behavior: A comparison of biweekly, three-month, and twelve-month self-reports. AIDS Educ Prev 1991;3:207-214.
43. Pinkerton SD, Benotsch EG, Mikytuck JM. When do simpler sexual behavior data collection techniques suffice? An analysis of consequent uncertainty in HIV acquisition risk estimates. Eval Rev 2007;31:401-412.
44. Hays WL. Statistics, 4th ed. Fort Worth, TX: Holt, Rinehart, and Winston, 1988.
45. Pfizer. Viagra (sildenafil citrate) tablets [patient information]. Revised October 2007. www.pfizer.com=pfizer=download= uspi-viagra.pdf (Last accessed January 2, 2009).
46. Bayer Pharmaceuticals Corporation. Levitra (vardenafil HCL) tablets [patient information], revised May 2008. www .univgraph.com=bayer=inserts= levitra.pdf (Last accessed January 2, 2009).
47. Eli Lilly and Company. Cialis (tadalafil) tablets [patient information], revised January 7, 2008. http:==pi.lilly.com=us= cialis-ppi.pdf (Last accessed January 2, 2009).
48. Ong LML, de Haes JCJM Hoos AM, Lammes FB. Doctor- patient communication: A review of the literature. Soc Sci Med 1995;40:903-918.
49. Piscitelli SC, Gallicano KD. Interactions among drugs for HIV and opportunistic infections. N Engl J Med 2001;44:984-996.
50. James JS. Viagra warning re: "poppers" and notice re: protease inhibitors. AIDS Treat News 1998;294:1.
51. Cohen DJ, Bruce KE. Sex and mortality: Real risk and perceived vulnerability. J Sex Res 1997;34:279-291.
52. Katz MH, Gerberding JL. Postexposure treatment of people exposed to the human immunodeficiency virus through sexual contact or injection-drug use. N Engl J Med 1997;336: 1097-1100.
53. Pinkerton SD, Holtgrave DR, Bloom FR. Cost-effectiveness of post-exposure prophylaxis following sexual exposure to HIV. AIDS 1998;12:1067-1078.